ロード中...
The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
BACKGROUND: OnabotulinumtoxinA has been shown to reduce headache-days among patients with chronic migraine (CM). The objective of this analysis was to determine whether onabotulinumtoxinA has an impact on headache-day severity in patients with CM among those patients who were deemed non-responders b...
保存先:
| 出版年: | J Headache Pain |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Milan
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5539058/ https://ncbi.nlm.nih.gov/pubmed/28766236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-017-0784-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|